Anbio Biotechnology (NNNN) Total Liabilities (2023 - 2025)

Historic Total Liabilities for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $131.1 billion.

  • Anbio Biotechnology's Total Liabilities changed N/A to $131.1 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $131.1 billion, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is 7423.26% up from last year.
  • Anbio Biotechnology's Total Liabilities amounted to $131.1 billion in Q2 2025.
  • Over the past 5 years, Anbio Biotechnology's Total Liabilities peaked at $131.1 billion during Q2 2025, and registered a low of $993060.0 during Q4 2023.
  • For the 3-year period, Anbio Biotechnology's Total Liabilities averaged around $43.7 billion, with its median value being $1.7 million (2024).
  • Data for Anbio Biotechnology's Total Liabilities shows a peak YoY increase of 7423.26% (in 2024) and a maximum YoY decrease of 7423.26% (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows Anbio Biotechnology's Total Liabilities stood at $993060.0 in 2023, then skyrocketed by 74.23% to $1.7 million in 2024, then surged by 7578470.3% to $131.1 billion in 2025.
  • Its last three reported values are $131.1 billion in Q2 2025, $1.7 million for Q4 2024, and $993060.0 during Q4 2023.